
At Balcanns, we’re dedicated to producing low-cost, GMP-certified medicinal cannabis to supply the EU and other key markets with premium extracts.
We leverage our Canadian expertise and technology to produce industry-leading medicinal cannabis at our state-of-the-art facilities in North Macedonia.
North Macedonia is a globally competitive, low-cost jurisdiction that is in the process of entering the EU.
The country possesses an ideal climate for cannabis production and a strong history of commercial horticulture.
Combined with cutting edge production and extraction technologies, our goal is to produce and deliver unrivaled premium medical cannabis extracts to countries across Europe and around the world.

Our Offering
We’ve secured the rights to a 22-hectare/54 acre compound located near Prilep, North Macedonia.
We will leverage our Canadian expertise and technology to produce industry-leading medicinal cannabis at our state-of-the-art facilities in North Macedonia.

Opportunity in Europe
Europe possesses the largest medical cannabis market in the world
742 Million People
€2.3 Trillion Euro annual healthcare expenditure
€58 Billion in forecasted market value by 2028






Why North Macedonia
North Macedonia is strategically positioned to produce high-end, premium cannabis products at a low cost.
Benefits Include:
- Potentially entering the EU & NATO
- Low corporate tax rate (10%)
- Favorable legal climate
- Strategic geographic position: Well positioned to supply key European cannabis markets
- Qualified labour force at globally competitive costs
- 10th on World Bank ‘Ease of Doing Business’ List
- Ideal climate for cannabis production

Success to Date
Request Investor Deck
Complete the form below to receive our full investors deck to find out more.
